Review



monoclonal antibody against mouse fabp5  (Danaher Inc)


Bioz Verified Symbol Danaher Inc is a verified supplier
Bioz Manufacturer Symbol Danaher Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Danaher Inc monoclonal antibody against mouse fabp5
    Monoclonal Antibody Against Mouse Fabp5, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/monoclonal antibody against mouse fabp5/product/Danaher Inc
    Average 86 stars, based on 1 article reviews
    monoclonal antibody against mouse fabp5 - by Bioz Stars, 2025-02
    86/100 stars

    Images



    Similar Products

    86
    Danaher Inc monoclonal antibody against mouse fabp5
    Monoclonal Antibody Against Mouse Fabp5, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/monoclonal antibody against mouse fabp5/product/Danaher Inc
    Average 86 stars, based on 1 article reviews
    monoclonal antibody against mouse fabp5 - by Bioz Stars, 2025-02
    86/100 stars
      Buy from Supplier

    86
    R&D Systems Hematology goat anti fabp5
    Goat Anti Fabp5, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat anti fabp5/product/R&D Systems Hematology
    Average 86 stars, based on 1 article reviews
    goat anti fabp5 - by Bioz Stars, 2025-02
    86/100 stars
      Buy from Supplier

    86
    Zambon fabp5 proteins
    Fabp5 Proteins, supplied by Zambon, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fabp5 proteins/product/Zambon
    Average 86 stars, based on 1 article reviews
    fabp5 proteins - by Bioz Stars, 2025-02
    86/100 stars
      Buy from Supplier

    86
    Proteintech anti fabp5 antibody
    a , Experimental schematic of untargeted metabolomic profiling on the culture supernatant of IECs isolated from Tm6sf2 ΔIEC and Tm6sf2 fl mice. Created with BioRender.com . b , PCA analysis and heat map of differential metabolites secreted by IECs from mice ( n = 8 per group). c , Metabolomics targeting free fatty acids on the cultural supernatant of isolated IECs ( n = 8 per group). d , Representative small intestine images of H&E staining and intestinal triglyceride of Tm6sf2 ΔIEC mice fed with NC ( n = 5 per group) or CD-HFD ( n = 9 per group). e , Silver staining coupled with mass spectrometry analysis after pull-down assay on mouse intestinal tissues. f , Co-immunoprecipitation of TM6SF2 and <t>FABP5</t> using mouse intestinal proteins. g , MST assay for direct binding between TM6SF2 and FABP5 with dissociation constant ( K d ) provided. h , Representative structure of molecular docking between TM6SF2 (purple) and FABP5 (blue). i , Metabolomics targeting free fatty acids in TM6SF2 KO Caco2 cells with or without FABP5 overexpression ( n = 6 per group). j , Experimental schematic and intestinal permeability by FITC-labelled dextran assay in mice supplemented with the top differential free fatty acids ( n = 5 per group). k , Permeability of Caco2 cell monolayers treated with arachidic acid or arachidonic acid ( n = 3 per group). l , m , Heat map of differential faecal microorganisms ( l ) and LPA-targeting metabolomics on portal vein serum ( m ) of mice treated with free fatty acids ( n = 4–5 per group). Results are presented as the mean ± s.d. Experiments were repeated three times with similar results ( e and f ). Statistical significance was determined by two-tailed Student’s t -test ( c , d , i and k ) or one-way ANOVA followed by Turkey’s multiple comparison ( j and m ).
    Anti Fabp5 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti fabp5 antibody/product/Proteintech
    Average 86 stars, based on 1 article reviews
    anti fabp5 antibody - by Bioz Stars, 2025-02
    86/100 stars
      Buy from Supplier

    86
    Proteintech antibodies against fabp5
    a , Experimental schematic of untargeted metabolomic profiling on the culture supernatant of IECs isolated from Tm6sf2 ΔIEC and Tm6sf2 fl mice. Created with BioRender.com . b , PCA analysis and heat map of differential metabolites secreted by IECs from mice ( n = 8 per group). c , Metabolomics targeting free fatty acids on the cultural supernatant of isolated IECs ( n = 8 per group). d , Representative small intestine images of H&E staining and intestinal triglyceride of Tm6sf2 ΔIEC mice fed with NC ( n = 5 per group) or CD-HFD ( n = 9 per group). e , Silver staining coupled with mass spectrometry analysis after pull-down assay on mouse intestinal tissues. f , Co-immunoprecipitation of TM6SF2 and <t>FABP5</t> using mouse intestinal proteins. g , MST assay for direct binding between TM6SF2 and FABP5 with dissociation constant ( K d ) provided. h , Representative structure of molecular docking between TM6SF2 (purple) and FABP5 (blue). i , Metabolomics targeting free fatty acids in TM6SF2 KO Caco2 cells with or without FABP5 overexpression ( n = 6 per group). j , Experimental schematic and intestinal permeability by FITC-labelled dextran assay in mice supplemented with the top differential free fatty acids ( n = 5 per group). k , Permeability of Caco2 cell monolayers treated with arachidic acid or arachidonic acid ( n = 3 per group). l , m , Heat map of differential faecal microorganisms ( l ) and LPA-targeting metabolomics on portal vein serum ( m ) of mice treated with free fatty acids ( n = 4–5 per group). Results are presented as the mean ± s.d. Experiments were repeated three times with similar results ( e and f ). Statistical significance was determined by two-tailed Student’s t -test ( c , d , i and k ) or one-way ANOVA followed by Turkey’s multiple comparison ( j and m ).
    Antibodies Against Fabp5, supplied by Proteintech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against fabp5/product/Proteintech
    Average 86 stars, based on 1 article reviews
    antibodies against fabp5 - by Bioz Stars, 2025-02
    86/100 stars
      Buy from Supplier

    86
    MyBiosource Biotechnology protein 5 fabp5 serum levels
    a , Experimental schematic of untargeted metabolomic profiling on the culture supernatant of IECs isolated from Tm6sf2 ΔIEC and Tm6sf2 fl mice. Created with BioRender.com . b , PCA analysis and heat map of differential metabolites secreted by IECs from mice ( n = 8 per group). c , Metabolomics targeting free fatty acids on the cultural supernatant of isolated IECs ( n = 8 per group). d , Representative small intestine images of H&E staining and intestinal triglyceride of Tm6sf2 ΔIEC mice fed with NC ( n = 5 per group) or CD-HFD ( n = 9 per group). e , Silver staining coupled with mass spectrometry analysis after pull-down assay on mouse intestinal tissues. f , Co-immunoprecipitation of TM6SF2 and <t>FABP5</t> using mouse intestinal proteins. g , MST assay for direct binding between TM6SF2 and FABP5 with dissociation constant ( K d ) provided. h , Representative structure of molecular docking between TM6SF2 (purple) and FABP5 (blue). i , Metabolomics targeting free fatty acids in TM6SF2 KO Caco2 cells with or without FABP5 overexpression ( n = 6 per group). j , Experimental schematic and intestinal permeability by FITC-labelled dextran assay in mice supplemented with the top differential free fatty acids ( n = 5 per group). k , Permeability of Caco2 cell monolayers treated with arachidic acid or arachidonic acid ( n = 3 per group). l , m , Heat map of differential faecal microorganisms ( l ) and LPA-targeting metabolomics on portal vein serum ( m ) of mice treated with free fatty acids ( n = 4–5 per group). Results are presented as the mean ± s.d. Experiments were repeated three times with similar results ( e and f ). Statistical significance was determined by two-tailed Student’s t -test ( c , d , i and k ) or one-way ANOVA followed by Turkey’s multiple comparison ( j and m ).
    Protein 5 Fabp5 Serum Levels, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/protein 5 fabp5 serum levels/product/MyBiosource Biotechnology
    Average 86 stars, based on 1 article reviews
    protein 5 fabp5 serum levels - by Bioz Stars, 2025-02
    86/100 stars
      Buy from Supplier

    86
    Danaher Inc fabp5
    a , Experimental schematic of untargeted metabolomic profiling on the culture supernatant of IECs isolated from Tm6sf2 ΔIEC and Tm6sf2 fl mice. Created with BioRender.com . b , PCA analysis and heat map of differential metabolites secreted by IECs from mice ( n = 8 per group). c , Metabolomics targeting free fatty acids on the cultural supernatant of isolated IECs ( n = 8 per group). d , Representative small intestine images of H&E staining and intestinal triglyceride of Tm6sf2 ΔIEC mice fed with NC ( n = 5 per group) or CD-HFD ( n = 9 per group). e , Silver staining coupled with mass spectrometry analysis after pull-down assay on mouse intestinal tissues. f , Co-immunoprecipitation of TM6SF2 and <t>FABP5</t> using mouse intestinal proteins. g , MST assay for direct binding between TM6SF2 and FABP5 with dissociation constant ( K d ) provided. h , Representative structure of molecular docking between TM6SF2 (purple) and FABP5 (blue). i , Metabolomics targeting free fatty acids in TM6SF2 KO Caco2 cells with or without FABP5 overexpression ( n = 6 per group). j , Experimental schematic and intestinal permeability by FITC-labelled dextran assay in mice supplemented with the top differential free fatty acids ( n = 5 per group). k , Permeability of Caco2 cell monolayers treated with arachidic acid or arachidonic acid ( n = 3 per group). l , m , Heat map of differential faecal microorganisms ( l ) and LPA-targeting metabolomics on portal vein serum ( m ) of mice treated with free fatty acids ( n = 4–5 per group). Results are presented as the mean ± s.d. Experiments were repeated three times with similar results ( e and f ). Statistical significance was determined by two-tailed Student’s t -test ( c , d , i and k ) or one-way ANOVA followed by Turkey’s multiple comparison ( j and m ).
    Fabp5, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fabp5/product/Danaher Inc
    Average 86 stars, based on 1 article reviews
    fabp5 - by Bioz Stars, 2025-02
    86/100 stars
      Buy from Supplier

    86
    Bioassay Technology Laboratory human fabp5 elisa kit
    a , Experimental schematic of untargeted metabolomic profiling on the culture supernatant of IECs isolated from Tm6sf2 ΔIEC and Tm6sf2 fl mice. Created with BioRender.com . b , PCA analysis and heat map of differential metabolites secreted by IECs from mice ( n = 8 per group). c , Metabolomics targeting free fatty acids on the cultural supernatant of isolated IECs ( n = 8 per group). d , Representative small intestine images of H&E staining and intestinal triglyceride of Tm6sf2 ΔIEC mice fed with NC ( n = 5 per group) or CD-HFD ( n = 9 per group). e , Silver staining coupled with mass spectrometry analysis after pull-down assay on mouse intestinal tissues. f , Co-immunoprecipitation of TM6SF2 and <t>FABP5</t> using mouse intestinal proteins. g , MST assay for direct binding between TM6SF2 and FABP5 with dissociation constant ( K d ) provided. h , Representative structure of molecular docking between TM6SF2 (purple) and FABP5 (blue). i , Metabolomics targeting free fatty acids in TM6SF2 KO Caco2 cells with or without FABP5 overexpression ( n = 6 per group). j , Experimental schematic and intestinal permeability by FITC-labelled dextran assay in mice supplemented with the top differential free fatty acids ( n = 5 per group). k , Permeability of Caco2 cell monolayers treated with arachidic acid or arachidonic acid ( n = 3 per group). l , m , Heat map of differential faecal microorganisms ( l ) and LPA-targeting metabolomics on portal vein serum ( m ) of mice treated with free fatty acids ( n = 4–5 per group). Results are presented as the mean ± s.d. Experiments were repeated three times with similar results ( e and f ). Statistical significance was determined by two-tailed Student’s t -test ( c , d , i and k ) or one-way ANOVA followed by Turkey’s multiple comparison ( j and m ).
    Human Fabp5 Elisa Kit, supplied by Bioassay Technology Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human fabp5 elisa kit/product/Bioassay Technology Laboratory
    Average 86 stars, based on 1 article reviews
    human fabp5 elisa kit - by Bioz Stars, 2025-02
    86/100 stars
      Buy from Supplier

    86
    Proteintech protein 5 fabp5
    Primers used for reverse transcription quantitative PCR.
    Protein 5 Fabp5, supplied by Proteintech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/protein 5 fabp5/product/Proteintech
    Average 86 stars, based on 1 article reviews
    protein 5 fabp5 - by Bioz Stars, 2025-02
    86/100 stars
      Buy from Supplier

    Image Search Results


    a , Experimental schematic of untargeted metabolomic profiling on the culture supernatant of IECs isolated from Tm6sf2 ΔIEC and Tm6sf2 fl mice. Created with BioRender.com . b , PCA analysis and heat map of differential metabolites secreted by IECs from mice ( n = 8 per group). c , Metabolomics targeting free fatty acids on the cultural supernatant of isolated IECs ( n = 8 per group). d , Representative small intestine images of H&E staining and intestinal triglyceride of Tm6sf2 ΔIEC mice fed with NC ( n = 5 per group) or CD-HFD ( n = 9 per group). e , Silver staining coupled with mass spectrometry analysis after pull-down assay on mouse intestinal tissues. f , Co-immunoprecipitation of TM6SF2 and FABP5 using mouse intestinal proteins. g , MST assay for direct binding between TM6SF2 and FABP5 with dissociation constant ( K d ) provided. h , Representative structure of molecular docking between TM6SF2 (purple) and FABP5 (blue). i , Metabolomics targeting free fatty acids in TM6SF2 KO Caco2 cells with or without FABP5 overexpression ( n = 6 per group). j , Experimental schematic and intestinal permeability by FITC-labelled dextran assay in mice supplemented with the top differential free fatty acids ( n = 5 per group). k , Permeability of Caco2 cell monolayers treated with arachidic acid or arachidonic acid ( n = 3 per group). l , m , Heat map of differential faecal microorganisms ( l ) and LPA-targeting metabolomics on portal vein serum ( m ) of mice treated with free fatty acids ( n = 4–5 per group). Results are presented as the mean ± s.d. Experiments were repeated three times with similar results ( e and f ). Statistical significance was determined by two-tailed Student’s t -test ( c , d , i and k ) or one-way ANOVA followed by Turkey’s multiple comparison ( j and m ).

    Journal: Nature Metabolism

    Article Title: Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut–liver axis

    doi: 10.1038/s42255-024-01177-7

    Figure Lengend Snippet: a , Experimental schematic of untargeted metabolomic profiling on the culture supernatant of IECs isolated from Tm6sf2 ΔIEC and Tm6sf2 fl mice. Created with BioRender.com . b , PCA analysis and heat map of differential metabolites secreted by IECs from mice ( n = 8 per group). c , Metabolomics targeting free fatty acids on the cultural supernatant of isolated IECs ( n = 8 per group). d , Representative small intestine images of H&E staining and intestinal triglyceride of Tm6sf2 ΔIEC mice fed with NC ( n = 5 per group) or CD-HFD ( n = 9 per group). e , Silver staining coupled with mass spectrometry analysis after pull-down assay on mouse intestinal tissues. f , Co-immunoprecipitation of TM6SF2 and FABP5 using mouse intestinal proteins. g , MST assay for direct binding between TM6SF2 and FABP5 with dissociation constant ( K d ) provided. h , Representative structure of molecular docking between TM6SF2 (purple) and FABP5 (blue). i , Metabolomics targeting free fatty acids in TM6SF2 KO Caco2 cells with or without FABP5 overexpression ( n = 6 per group). j , Experimental schematic and intestinal permeability by FITC-labelled dextran assay in mice supplemented with the top differential free fatty acids ( n = 5 per group). k , Permeability of Caco2 cell monolayers treated with arachidic acid or arachidonic acid ( n = 3 per group). l , m , Heat map of differential faecal microorganisms ( l ) and LPA-targeting metabolomics on portal vein serum ( m ) of mice treated with free fatty acids ( n = 4–5 per group). Results are presented as the mean ± s.d. Experiments were repeated three times with similar results ( e and f ). Statistical significance was determined by two-tailed Student’s t -test ( c , d , i and k ) or one-way ANOVA followed by Turkey’s multiple comparison ( j and m ).

    Article Snippet: The protein mixture was also incubated overnight at 4 °C with either anti-TM6SF2 antibody or anti-FABP5 antibody (RRID: AB_2100341, 12348-1-AP, Proteintech).

    Techniques: Isolation, Staining, Silver Staining, Mass Spectrometry, Pull Down Assay, Immunoprecipitation, Binding Assay, Over Expression, Permeability, Two Tailed Test, Comparison

    Primers used for reverse transcription quantitative PCR.

    Journal: Molecular Medicine Reports

    Article Title: Stigmasterol exerts antiglioma effects by regulating lipid metabolism

    doi: 10.3892/mmr.2024.13351

    Figure Lengend Snippet: Primers used for reverse transcription quantitative PCR.

    Article Snippet: The following primary antibodies were utilized for western blotting: Rabbit anti-fatty acid binding protein 5 (FABP5) antibody (1:2,000; cat. no. 12348-1-AP; Proteintech Group, Inc.), rabbit anti-α-1B adrenergic receptor (ADRA1B) antibody (1:1,000; cat. no. 22419-1-AP; Proteintech Group, Inc.) and mouse anti-β-actin antibody (1:5,000; cat. no. T0022; Affinity Biosciences).

    Techniques: Reverse Transcription, Sequencing

    Construction and validation of a prognostic model associated with stigmasterol target genes. (A) Venn diagram of potential targets of stigmasterol in the treatment of GBM, prognosis-related genes of patients with GBM and lipid metabolism-related genes. (B) Two prognosis-related target mRNAs of stigmasterol for GBM treatment were selected. (C and D) Least absolute shrinkage and selection operator variable screening process. (E) Distribution of survival status and risk score of patients with GBM in the training set. (F) Expression characteristics of the two prognosis-related target mRNAs of stigmasterol for GBM treatment in the training set. (G) ROC curve for patient survival of the training set. (H) Survival analysis between the two risk subgroups in the training set. (I) ROC curve for patient survival of the internal validation set. (J) Survival analysis between the two risk subgroups in the internal validation set. (K) ROC curve for patient survival of the external validation set. (L) Survival analysis between the two risk subgroups in the external validation set. GBM, glioblastoma; ROC, receiver operating characteristic; FABP5, fatty acid binding protein 5; ADRA1B, α-1B adrenergic receptor; AUC, area under the curve.

    Journal: Molecular Medicine Reports

    Article Title: Stigmasterol exerts antiglioma effects by regulating lipid metabolism

    doi: 10.3892/mmr.2024.13351

    Figure Lengend Snippet: Construction and validation of a prognostic model associated with stigmasterol target genes. (A) Venn diagram of potential targets of stigmasterol in the treatment of GBM, prognosis-related genes of patients with GBM and lipid metabolism-related genes. (B) Two prognosis-related target mRNAs of stigmasterol for GBM treatment were selected. (C and D) Least absolute shrinkage and selection operator variable screening process. (E) Distribution of survival status and risk score of patients with GBM in the training set. (F) Expression characteristics of the two prognosis-related target mRNAs of stigmasterol for GBM treatment in the training set. (G) ROC curve for patient survival of the training set. (H) Survival analysis between the two risk subgroups in the training set. (I) ROC curve for patient survival of the internal validation set. (J) Survival analysis between the two risk subgroups in the internal validation set. (K) ROC curve for patient survival of the external validation set. (L) Survival analysis between the two risk subgroups in the external validation set. GBM, glioblastoma; ROC, receiver operating characteristic; FABP5, fatty acid binding protein 5; ADRA1B, α-1B adrenergic receptor; AUC, area under the curve.

    Article Snippet: The following primary antibodies were utilized for western blotting: Rabbit anti-fatty acid binding protein 5 (FABP5) antibody (1:2,000; cat. no. 12348-1-AP; Proteintech Group, Inc.), rabbit anti-α-1B adrenergic receptor (ADRA1B) antibody (1:1,000; cat. no. 22419-1-AP; Proteintech Group, Inc.) and mouse anti-β-actin antibody (1:5,000; cat. no. T0022; Affinity Biosciences).

    Techniques: Selection, Expressing, Binding Assay

    Effects of stigmasterol on lipid metabolism and the expression of related target genes in GBM cells. (A) Effect of stigmasterol on free fatty acid levels in GBM cells. (B) Effect of stigmasterol on total cholesterol levels in GBM cells. (C) Effect of stigmasterol on the mRNA expression of the two target genes (FABP5 and ADRA1B) in GBM cells. (D) Effect of stigmasterol on the expression of the proteins encoded by the two target genes in GBM cells. (E) Molecular docking of the protein encoded by FABP5 with stigmasterol. (F) Molecular docking of the protein encoded by ADRA1B with stigmasterol. *P<0.05 and **P<0.01. GBM, glioblastoma; FABP5, fatty acid binding protein 5; ADRA1B, α-1B adrenergic receptor.

    Journal: Molecular Medicine Reports

    Article Title: Stigmasterol exerts antiglioma effects by regulating lipid metabolism

    doi: 10.3892/mmr.2024.13351

    Figure Lengend Snippet: Effects of stigmasterol on lipid metabolism and the expression of related target genes in GBM cells. (A) Effect of stigmasterol on free fatty acid levels in GBM cells. (B) Effect of stigmasterol on total cholesterol levels in GBM cells. (C) Effect of stigmasterol on the mRNA expression of the two target genes (FABP5 and ADRA1B) in GBM cells. (D) Effect of stigmasterol on the expression of the proteins encoded by the two target genes in GBM cells. (E) Molecular docking of the protein encoded by FABP5 with stigmasterol. (F) Molecular docking of the protein encoded by ADRA1B with stigmasterol. *P<0.05 and **P<0.01. GBM, glioblastoma; FABP5, fatty acid binding protein 5; ADRA1B, α-1B adrenergic receptor.

    Article Snippet: The following primary antibodies were utilized for western blotting: Rabbit anti-fatty acid binding protein 5 (FABP5) antibody (1:2,000; cat. no. 12348-1-AP; Proteintech Group, Inc.), rabbit anti-α-1B adrenergic receptor (ADRA1B) antibody (1:1,000; cat. no. 22419-1-AP; Proteintech Group, Inc.) and mouse anti-β-actin antibody (1:5,000; cat. no. T0022; Affinity Biosciences).

    Techniques: Expressing, Binding Assay